EU extends grace period for transition to Medical Device Regulation
New course on good practices (GxP)
New courses on clinical trial safety reporting released
Fifty courses now available from Zenosis
New courses on clinical research under the EU Clinical Trials Regulation released
More Zenosis courses approved by Royal Society of Chemistry and Faculty of Pharmaceutical Medicine
Zenosis, the leading provider of eLearning for the medicinal products industry, is pleased to announce that a further two of its courses have been awarded Approved Training status by the UK's Royal Society of Chemistry. They have also received Continuing Professional Development (CPD) accreditation from the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians.
The courses are:
- ESS02: Essentials of Monoclonal Antibodies
- SUB12: Registration of Medicinal Products Based on Monoclonal Antibodies
In addition the Faculty has granted CPD accreditation to:
- SUB13: How to Gain Approval to Market a Generic Drug in the USA\
- SUB14: The Regulatory Pathway to Licensure of Follow-on Biologics (Biosimilars) in the USA
Approval by the Society identifies good quality training that supports members in their continuing professional development. The Society's approval process is one of peer review, involving assessment against set criteria by members expert in their field.
CPD refers to the learning activities through which professionals develop their abilities and ensure that they remain competent and increasingly effective. CPD is encouraged in all professions and is formally required in some. It may be otherwise known as Continuing Professional Education (CPE) or, in the context of medicine, Continuing Medical Education (CME).